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Abstract A validated ultrahigh-performance liquid chro-
matography method using 1.7 μm core–shell particles is
presented for the identification and quantification of β-
carotene (BC) and related cleavage products (CPs) in
primary cell culture media. Besides BC, apo-4′-, apo-8′-,
apo-10′-, and apo-12′-carotenals, as well as 5,6-epoxy-β-
carotene, were selected as target analytes. Detection was
performed via an 80-Hz diode array detector and an
electrospray ionization–linear quadrupole ion trap–Orbitrap
XL mass spectrometer, both hyphenated in series. Total
analysis time was below 6 min with peak widths <12 s.
Addition of trifluoroacetic acid and tetrahydrofuran to the
mobile phase allowed for the mass spectrometric detection
of BC and related CPs and reduced peak tailing due to
improved solubility of hydrophobic analytes. Intra-day and
inter-day precision for UV and mass spectrometric detec-
tion were ≤1.5 % for retention times and ≤5.1 % for peak
areas. Instrumental linearity was confirmed by Mandel’s
fitting test between 0.25 (or 1.00 μg/mL) and 5.00 μg/mL
for UV detection. The higher sensitivity of mass spectro-
metric detection allowed for the coverage of three concen-
tration domains between 0.025 and 5.00 μg/mL in linearity
testing. Homoscedasticity was confirmed between 0.10 and
5.00 μg/mL for Orbitrap XL MS. The limits of quantifica-
tion were between 52.6 and 889.4 ng/mL for UV detection
and between 19.3 and 102.4 ng/L for mass spectrometric
detection. Offline solid-phase extraction from culture me-
dia fortified with BC and CPs provided intra- and inter-
day recoveries between 65.8 and 102.4 % with coeffi-
cients of variation ≤6.2 %. Primary rat hepatocyte cultures
treated with BC and subjected to different oxidative stress
conditions contained 5,6-epoxy-BC and apo-4′-carotenal
besides residual BC. Apparently, 5,6-epoxy-BC was
formed in the medium via autoxidation of BC by ambient
oxygen.
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CPs Cleavage products of β-carotene
CV Coefficient of variation
DAD Diode array detection
DMNQ 2,3-Dimethoxy-1,4-naphthoquinone
EICC Extracted ion current chromatogram
GC–EI–MS Gas chromatography–electron ionization–
mass spectrometry
IS Internal standard
LOD Limit of detection
LOQ Limit of quantification
LTQ Linear quadrupole ion trap
MEM Minimum essential medium Eagle
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Carotenoids and particularly β-carotene (BC)—a precursor of
vitamin A—have been assigned beneficial health effects [1]
including a prominent role in the prevention of cataract, senile
macular degeneration, cardiovascular diseases, neurodegener-
ative diseases, cancer, and in cancer therapy [2, 3]. Several
studies have provided evidence for anti-oxidative effects of
BC by quenching singlet oxygen and scavenging peroxy
radicals [4, 5]. Thus, BC has been applied comprehensively
inmicro-supplementation [6]. Besides, BC and its degradation
product apo-8′-carotenal were frequently applied as food and
beverage colorants E 160 a and E 160 e [7].
Nonetheless, certain frame conditions trigger pro-oxidative
and pro-carcinogenic effects of carotenoids [8, 9]. High oxy-
gen pressure, pronounced oxidative stress, and BC adminis-
tration at elevated doses apparently promote adverse effects
[4, 10]. Two large-scale human intervention trials, i.e., the
ATBC [11] and the Carotene and Retinol Efficacy (CARET)
[12, 13] studies, have addressed this paradox by oral long-
term administration of 20–30 mg BC/day to human probands.
Test persons comprised inter alia cigarette smokers and
workers exposed to asbestos. These groups showed a 16–
28 % increased lung cancer incidence with higher mortality
risk when compared to control groups which requested the
termination of the CARET trial ahead of schedule [12, 13].
Other BC supplementation studies, such as the Physician
Health Study (PHS) [14] and the Linxian Trial [15, 16],
revealed no effect on the health state or demonstrated indeed
reduced cancer-related mortality [5, 14]. Different dietary
basis uptake of BC and pre-existing tumors might explain
divergent study results [5, 16].
Adverse effects in humans have been mimicked in animal
models sharing physiological similarity in BC adsorption and
tissue metabolism, i.e., ferrets [2, 16]. Thereby, BC supple-
mentation at pharmacological doses was combined with ex-
posure to cigarette smoke [17]. The high number of free
radicals prevailing in cigarette smoke promotes the formation
of BC oxidation products (= cleavage products (CPs)) [18].
Moreover, CPs, such as apo-10′- [19] and apo-14′-carotenal,
have also promoted the binding of benzo[a]pyrene to DNA
[16]. Apparently, the described BC paradox was not evoked
by BC per se but by its degradation products (CPs) generated
by eccentric cleavage as stated elsewhere [16, 18, 20]. This
has been corroborated by recent studies on primary rat hepa-
tocytes treated with apo-8′-carotenal and CP mixtures [21,
22]. Non-volatile CPs, e.g., apo-carotenals, epoxides, and
carbonyls, are generated by hypochloric acid (HClO) that is
formed by myeloperoxidase secreted from activated phago-
cytes [23]. The reaction mechanism between BC and HClO
has been mimicked in vitro by Handelman et al. [24]
and revealed a comprehensive set of CPs. The proposed
eccentric degradation products [25] are also present to a
minor extent in intestinal mucosa cells and hepatic cells
due to the presence of β-carotene-9′,10′-monooxygenase
(BCO 2) [26, 27].
Carotenoids have preferably been analyzed by high-
performance liquid chromatography (HPLC) with porous
C18 [28, 29] and C30 [7, 30–33] particles employing UV
[19, 29, 31, 33, 34], quadrupole mass spectrometric (MS)
[19, 35], and ion-trap MS detection [32]. Contrary to
carotenoid mixtures, CPs, such as apo-carotenals, have
scarcely been addressed [24, 36, 28, 37] and yet less
frequently in cells or cell cultures [34]. HPLC separations
with totally porous particles suffer from extended analysis
times, i.e., 20–83 min for carotenoid mixtures [6, 7, 30,
31, 33] and BC with related CPs [3, 24]. Ultrahigh-
performance LC (UHPLC) [38] offers improved selectivity
and accelerated separations [39, 40]. On the other hand,
superficially porous particles with a solid, impenetrable
core provide reduced back-pressure [41] and allow for
excellent reduced plate height values down to 1.1 [39,
42, 43].
Linear quadrupole ion trap (LTQ)–Orbitrap MS with
full scan option provides the possibility for a mid-term
untargeted strategy for high sensitivity, mass accuracy in
low parts per million range [44], and a mass resolution
of >100,000 (FWHM) [45]. Consistently, the hyphen-
ation of UHPLC to linear ion trap–Orbitrap MS repre-
sents a highly promising combination for UHPLC–MS
analysis of carotenoids.
The current work aims to develop and validate an
UHPLC–diode array detection (DAD)–electrospray ioniza-
tion (ESI)–Orbitrap MS method for BC and related CPs
selected from previously described degradation profiles
[24, 25] applying sub-2 μm core–shell particles with pre-
ceding offline solid-phase extraction (SPE). The combina-
tion with offline SPE intends to further reduce interfer-
ences [46]. Thereby, the SPE strategy recently developed
for volatile CPs [47] should be adopted to allow for a
simultaneous extraction of volatile and non-volatile CPs,
and BC with optional splitting of the eluate for final GC–
EI–MS [47] and UHPLC–DAD–ESI–Orbitrap MS analy-
ses. This combined extraction step for CPs of highly
variant properties provides an innovation in the analysis
of cell culture media. Analyte identification refers to a
combination of several decision parameters, i.e., tR, UV
spectra, accurate masses, and related natural isotopic
patterns.
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Materials and methods
Reagents and chemicals
All-trans-β-carotene (BC; purity ≥97.0 %), all-trans-β-apo-
8′-carotenal (apo-8′; purity ≥96.0 %), methanol (purity
≥99.9 %), n-hexane (in UniSolv quality), trifluoroacetic acid
(TFA; purity ≥99.5 %), H2O2 (in semi-conductor quality),
Fe(II)-lactate (purum ≥98 %), minimum essential medium
Eagle (MEM), and Tween 20 (for molecular biology) were
all obtained from Sigma-Aldrich/Fluka (St. Louis, MO,
USA). Methylisoeugenol (purity >98 %) was obtained from
SAFC (St. Louis, MO, USA) and used as internal standard
(IS) as outlined previously [47]. β-Apo-4′-carotenal (apo-4′),
β-apo-10′-carotenal (apo-10′), β-apo-12′-carotenal (apo-12′),
and 5,6-epoxy-carotenal (5,6-epoxy-BC) were received as
lyophilized powder from CaroteneNature GmbH (Lupsingen,
Switzerland) at 92–99 % purity and stored light protected at
−20 °C. Analyte structures are given in Fig. 1. Tetrahydrofu-
ran (THF; anhydrous and without stabilizer) was from Merck
(Darmstadt, Germany). Acetonitrile (ACN; Chromasolv, pu-
rity ≥99.8 %) was purchased from Promochem (Wesel, Ger-
many). 2,3-Dimethoxy-1,4-naphthoquinone (DMNQ; ≥99 %)
was obtained from Enzo Life Sciences (Lausen, Switzerland).
Ultrapure water was prepared by a Milli-Q Plus 185 system
(Millipore S.A., Molsheim, France). Nitrogen in 5.0 quality
was obtained from SIAD GmbH (St. Pantaleon, Austria).
Ultrahigh-performance liquid chromatography–diode array
detection–electrospray ionization–Orbitrap mass
spectrometry
UHPLC analyses were performed with an Accela System,
equipped with an Accela 1250 pump, an Accela 80-Hz diode
array detector with a wavelength range from 190 to 600 nm
and equipped with a 2-μl LightPipe flow cell (all from Ther-
mo Fisher Scientific, Palo Alto, CA, USA), and an LC PAL
DLW Option Autosampler (from CTC Analytics AG,
Zwingen, Switzerland). Acquisition of UV data was per-
formed at the respective absorbance maximum of either ana-
lyte (Table 1; Fig. 2). Due to the narrow peakwidths of 2–10 s,
a data sampling rate of 40 Hz was selected. The UHPLC
system was equipped with a 2-μl injection loop and a column
oven 200 (from Thermo Fisher Scientific), which was set to
50 °C. During the injection, the entire loop was filled. For
chromatographic separations, a Kinetex® C18 column (100×
2.1 mm ID, 1.7 μm, 100 Å; Phenomenex, Torrance, CA,
USA) with core–shell particles was operated at a flow rate
of 500μl/min. Separation was conducted by a ternary gradient
including (A) ultrapure water with 0.02 % (v/v) TFA, (B)
ACN with 0.02 % (v/v) TFA, and (C) 50 % (v/v) THF with
0.02 % (v/v) TFA (in ACN) employing the following gradient
program: 0.00 min—60 % A/20 % B/20 % C, 0.50 min—
60 % A/20 % B/20 % C, 2.00 min—10 % A/44 % B/46 % C,
5.00 min—10 % A/0 % B/90 % C, 7.00 min—10 % A/0 %
B/90 % C, 7.50 min—60 % A/20 % B/20 % C, and
9.00 min—60 % A/20 % B/20 % C. The UHPLC back-
pressure was between 750 and 950 bar during the separation.
Due to its high mass accuracy, mass stability, detection
sensitivity, and analyte specificity, Orbitrap MS was preferred
over time-of-flight MS or triple–quadrupole MS, allowing the
highly confident identification of the analytes extracted from
biological samples. Mass spectrometric measurements were
performed by an LTQ–Orbitrap XL mass spectrometer which
was hyphenated by the Ion Max ESI ion source (all from
Thermo Fisher Scientific) to the UHPLC system. Tuning of
the systemwas done in the automatic tunemode bymeans of a
100-μg/mL apo-8′ solution prepared in 50 % (v/v) THF–50 %
(v/v) ACN for the monoisotopic mass of [apo-8′+H+] at m/z
417.3, by adding the tuning solution to the column effluent via
a T-splitter. The optimized MS parameters included a heated
capillary temperature of 250 °C; sheath gas and auxiliary gas
flow of 30 and 15 arb. units, respectively; a source voltage of
+3.0 kV; a capillary voltage of 46.00 V; and a tube lens
voltage of 35.00 V. Calibration of the system was performed
according to the protocol of the manufacturer. Data acquisi-
tion in single ion monitoring (SIM) mode with the LTQ–
Orbitrap XL mass spectrometer addressed theoretical masses
of analytes with a tolerance window of ±0.5m/z. By reason of
the targeted approach in mass spectrometry, SIM mode is
preferred over full scan. Due to the analysis of cell culture







Fig. 1 Degradation scheme of all-trans BC (by HClO according to [25])
with structures and hydrophobicity values of related non-volatile target
cleavage products
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media, we can expect a number of other compounds present in
the sample apart from the target analytes. The SIM mode
enables to selectively address the exact molecular masses of
our target analytes which increases the clarity of the obtained
chromatograms and aids in data evaluation. Moreover, the
selective tuning for defined masses enhances the transmission
thus improving sensitivity. For the extracted ion current chro-
matograms (EICC) corresponding masses were selected with a
reduced mass width of ±0.05m/z. To address target analytes,
masses were therefore set tom/z 351.26 and 377.28 for the first
3.60 min, then switched to m/z 417.31 from 3.60 to 3.85 min,
tom/z 483.36 up to 4.20min, tom/z 553.44 up to 5.00min, and
finally to m/z 536.43 from 5.00 min to the end of the run.
Standard solution for UHPLC–DAD–ESI–Orbitrap MS
instrumental validation
Single standard solutions of BC, of the selected apo-
carotenals, and of 5,6-epoxy-BCwere prepared gravimetrical-
ly at nominal 1.0 mg/mL in 50 % (v/v) ACN–50 % (v/v) THF.
These single standard solutions were used to prepare 1.0 mL
of a composite standard stock solution with 100 μg/mL for
either compound by mixing them in an appropriate ratio and
adjusting the final volume with 50 % (v/v) ACN–50 % (v/v)
THF. This composite stock solution was light-protected and
stored under nitrogen at +4 °C. From this composite stock
solution, working standard solutions for calibration and for
linearity testing were freshly prepared by dilution to appropri-
ate concentrations with ACN and THF (50:50 % (v/v)) imme-
diately prior to their injection into the UHPLC–DAD–ESI–
Orbitrap MS system. Therefore, different concentration
ranges, i.e., 0.025–0.10, 0.10–1.0, and 1.0–5.0 μg/mL, were
considered.
Standard solutions for validation of SPE offline coupled
to UHPLC–DAD–ESI–Orbitrap MS
A composite standard stock solution containing BC and all
target CPs at 200 μg/mL, respectively, was prepared in an
aqueous 9.5 mmol/L Tween 20 solution. Methylisoeugenol,
which was previously employed as IS to correct for differ-
ences in the SPE efficacy [47], was also applied for BC and
non-volatile CPs and included at 200 μg/mL in the composite
standard. This composite stock solution was diluted with
MEM at ratios of either 1:200 (v/v) or 1:400 (v/v) to give
working solutions of 1.0 or 0.5 μg/mL for BC and individual
CPs, respectively. Working solutions were prepared immedi-
ately prior to their application in SPE and employed for the
determination of SPE recoveries at these concentrations as
well as in the inter- and intra-day assays for the selected SPE
adsorbent.
Solid-phase extraction
Strata Phenyl 500 mg/3 mL SPE columns were obtained
from Phenomenex and applied in the SPE optimization for
BC and apo-carotenals. The SPE procedure is based on a
recently published SPE method for volatile cleavage prod-
ucts of β-carotene [47]. Briefly, SPE columns were con-
ditioned with 3 mL methanol followed by 3 mL ultrapure
water before 1.0 mL of blanks, of the respective MEM
working solution—spiked either with β-carotene and the
internal standard or β-carotene, related cleavage products,
and the internal standard—or of the cell culture medium
after incubation was loaded. The column was then washed
with 2 mL ultrapure water. Elution of β-carotene, non-
volatile cleavage products, and methylisoeugenol (IS) was
done with 2.0 mL 10 % (v/v) THF in n-hexane at a flow
rate ≥2 mL/min to comply with the SPE requirements of
volatile cleavage products measurements by GC–EI–MS.
The eluate was cooled to −20 °C to facilitate the separa-
tion of the organic and aqueous phase. The hydrophobic
fraction of the eluate was then collected [47]. The imple-
mentation of this SPE strategy offers a simultaneous ex-
traction of volatile and non-volatile CPs for future analy-
ses with subsequent equal splitting of the 2-mL eluate for
GC–EI–MS and UHPLC–DAD–ESI–Orbitrap MS, respec-
tively. When analyzing only BC and non-volatile CPs, the
entire eluate can alternatively be transferred to a Kuderna
Danish micro-evaporator system and evaporated to dryness
under a gentle stream of nitrogen. Residues were
reconstituted in 1.0 mL 50 % (v/v) ACN–50 % (v/v)
THF and then injected directly into the UHPLC–DAD–
ESI–Orbitrap MS system.
Table 1 Survey of retention times and detection wavelengths (according to the absorbance maxima derived from Fig. 2b) as well as theoretical and
recorded m/z for target CPs and BC with optimized UHPLC–DAD–ESI–Orbitrap MS
Apo-12′-carotenal Apo-10′-carotenal Apo-8′-carotenal Apo-4′-carotenal 5,6-Epoxy-carotenal β-Carotene
Retention time (min) 3.43 3.47 3.70 3.97 4.76 5.35
Wavelengths (nm) 425 450 470 490 430 460
m/ztheor 351.26824 377.28389 417.31519 483.36214 553.44039 536.43765
m/zdetect 351.26794 377.28400 417.31375 483.36129 553.44067 536.43713
ppm <1.5 <1.5 <3.5 <2.0 <1.0 <2.0
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Solutions for treatment of cell cultures
Stock solutions of BC for controls and cell treatment were
prepared at 10 mmol/L in 9.5 mmol/L aqueous Tween 20
solution. This stock solution was diluted 1:100 (v/v) with
MEM to provide a final concentration of 100 μmol/L BC.
An appropriate volume of this diluted BC treatment solution
was then spiked to the cell culture medium to make up a
further 1:10 dilution. Consistently, the final concentration in
the cell culture was 10 μmol/L BC including also 9.5 μmol/L
Tween 20. Prior to the addition to cell cultures, the spiked
culture medium is mixed to assure a homogenous solution.
b
a
Fig. 2 a UHPLC chromatogram acquired at 460 nm for a standard solution containing BC and CPs at 1.0 μg/mL. b Corresponding UV spectra of: A
apo-12′-carotenal, B apo-10′-carotenal, C apo-8′-carotenal, D apo-4′-carotenal, E 5,6-epoxy-carotenal, and F β-carotene
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Cytotoxic effects in cell cultures of primary hepatocytes of
female Fischer 344 rats were absent at the tested Tween 20
concentration in MEM. DMNQ, H2O2, and iron lactate stock
solutions were all prepared at 1.0 mmol/L in serum-freeMEM,
respectively.
Primary hepatocyte cultures
Primary hepatocytes were chosen as a model system because
the culture medium is not supplemented with serum (regularly
10–20 %) and contains only proteins excreted by the cells
[48], thus facilitating the chemical analysis. Primary paren-
chymal hepatocytes were prepared from female Fischer 344
rats according to the protocols given elsewhere [48, 49].
Isolated primary hepatocytes were cultivated in 5 mL serum-
free MEM supplemented with non-essential amino acids,
pyruvate (1 mmol/L), aspartate (0.20 mmol/L), serine
(0.20 mmol/L), and penicillin (100 U)/streptomycin
(100 μg/mL) in collagen-coated 60-mm-diameter plastic cul-
ture dishes for 21 h with change of the culture medium after
the first 3 h. After these 21 h, incubation of cells with the
respective treatment solutions was performed directly without
any further change of medium for 3 h. Incubation under
control conditions was done at 37 °C, 5 % CO2, and 95 %
relative humidity without oxidative stress treatment applying
either culture medium alone (i.e., deficient of Tween 20 and
BC) or fortified with appropriate volumes of DMNQ, H2O2,
or Fe++ stock solutions. Fortified culture media were prepared
immediately prior to their application, which was done by
replacing the medium after 21 h incubation. In case of treat-
ment, primary hepatocytes were incubated with 10 μmol/L
BC and concurrent oxidative stress.
Cell treatment with BC under oxidative stress
Different approaches were applied to mimic the oxidative
stress of the risk groups in the chemoprevention trials
employing the validated SPE UHPLC–DAD–ESI–Orbitrap
MS method to culture media. The tested treatment solutions
for primary hepatocytes address in vitro degradation of BC to
non-volatile CPs over the incubation interval, subsequent to
BC spiking to the cell culture medium. In case of treatment
under different prooxidant conditions, primary hepatocytes
were incubated for 3 h with 10 μmol/L BC in the presence
of either (i) 40 μmol/L DMNQ, (ii) 10 μmol/L H2O2, or (iii) a
combination of 10μmol/LH2O2 and 10μmol/L Fe(II)lactate—
the latter subsequently termed “Fenton condition” [50]. Cul-
tures exposed to these regimens without addition of BC served
as references for oxidative conditions. For chemical analysis,
the culture supernatants were collected immediately after the
3-h treatment period and subjected to SPE. For cultures treated
with BC and subsequent oxidative stress, hepatocytes from two
different animals were prepared on different days. Hepatocytes
of each rat were cultivated in three separate Petri dishes, re-
spectively. For either Petri dish, one SPE was performed and
the final eluate analyzed in triplicate.
Statistical treatment
Data were statistically evaluated by means of the SPSS Sta-
tistical Software Package version 16 applying appropriate test
procedures, e.g., one-way analysis of variance (ANOVA),
Levene’s test, and independent t test. Mandel’s fitting test
(MFT) is not included as standard SPSS operation and was
thus established via the SPSS syntax function. Details of the
calculation procedure have been outlined recently [47] and are
briefly recalled in the respective sections. Results were con-
sidered significant at p<0.05.
Result and discussion
The selection of non-volatile target analytes, i.e., apo-
carotenals and 5,6-epoxy-BC, was based on the constituent
profiles of CPs previously described for the in vitro cleavage
of BC with HClO [24] and for activated neutrophils [10] and
other cells, such as pneumocytes [34], when incubated with
BC.
UHPLC with core–shell columns
Currently, UHPLC separations have been merely published
for carotenoids, retinol and tocopherol [33, 51], but not for BC
and related CPs, i.e., apo-carotenals. In comparison to previ-
ously published HPLC separations for apo-carotenals which
required 30–40 min total analysis time [52], the developed
UHPLC separation was performed in less than 6 min with
peak widths at base of analyte peaks smaller than 12 s. The
gradient composition and programming were essential to
achieve narrow peak widths and avoid precipitation as well
as trapping of highly hydrophobic analytes on the column.
Therefore, a ternary gradient composed of ultrapure water,
ACN, and THF was crucial for dissolving moderately and
highly hydrophobic analytes in a moderate hydrophilic
solution.
TFA has been added both to reduce secondary ionic inter-
actions by shielding residual silanol groups [53] and reduce
the pH in the mobile phase to promote ionization in positive
mode. During the optimization of the UHPLC separation,
severe tailing of the BC peak due to a restricted solubility
[54] was an issue of concern (data not shown). Therefore, the
THF content in the mobile phase was stepwise increased
within the gradient up to final 45 % (v/v) immediately before
BC was passing the detector. This improved peak shape and
symmetry substantially and is in accordance with recent strat-
egies [19]. Although a minor tailing of the BC peak persisted
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under the selected conditions (Fig. 2a), an increase beyond the
selected THF content showed no further improvement (data
not shown). UV spectra for BC and related CPs recorded
under the selected UHPLC conditions are depicted in
Fig. 2b together with related absorbance maxima (Table 1).
These wavelengths were also selected for detection of analytes
and validation of UHPLC–DAD. The maximum at 458 nm
and the side maximum at 487 nm for BC correspond to
previous data [36] despite a minor shift which is related to
the different compositions of the mobile phase [54]. Apo-
carotenals showed an increase in their respective absorbance
maximum in the order of apo-12′ to apo-4′ due to the increase
in the polyene chain length [54], as described elsewhere [36,
28, 55]. As expected, the elution order of BC and related CPs
is governed by their hydrophobicity (Figs. 1 and 2a).
LTQ–Orbitrap MS
The lack of protonation sites in BC and other carotenes makes
their ionization in ESI–MS inefficient if not taking appropriate
means to ameliorate the situation. However, this does not refer
to the CPs which can be protonated (see structures in Fig. 1).
Ionization of BC has been realized either by post-column
addition of oxidizing agents, e.g., halogenated solvents [56],
or of silver salts [32, 57]. In the current case, ionization of BC
is effected upon electrochemical oxidation [58] with forma-
tion of radical ions (M•+) [56, 57]. Moreover, it has been
shown that electrochemical oxidation is supported under acid-
ic condition [56]. Contrary to BC, all target CPs are detected
as [M+H]+ under the selected conditions. EICCs of a standard
solution are depicted in Fig. 3. In addition, detected masses
and isotope patterns for BC and target apo-carotenals are
included and compared with their theoretical masses and
simulated isotope patterns (Fig. 4) which were used for for-
mula confirmation.
Solid-phase extraction in sample preparation
The concept of the presented SPE approach pursues the strat-
egy of a simultaneous extraction of physicochemically diver-
gent analytes, i.e., BC, non-volatile, and volatile CPs. Thus,
the UHPLC–DAD–ESI–OrbitrapMSmethod for non-volatile
CPs should share the SPE procedure with GC–EI–MS for
volatile CPs [47]. This strategy ensures identical adsorption
and elution conditions for all target analytes and reduces
variations in the SPE performance for individual analyte clas-
ses within the same sample. However, since GC–EI–MS and
UHPLC–DAD–ESI–OrbitrapMS are applied as final analysis
steps, a splitting of the eluate and change to solvents compat-
ible with the final separation and detection step are required.
As in GC–EI–MS, methylisoeugenol was applied as an IS to
correct quantification in UHPLC–DAD–ESI–LTQ–Orbitrap
MS.
Method validation
Instrument validation of UHPLC–DAD–ESI–Orbitrap MS
The developed UHPLC–DAD–ESI–OrbitrapMSmethodwas
subject of a single-laboratory validation according to the
IUPAC and the relevant ICH guideline Q2(R1) [59, 60].
Instrumental basis validation addressed intra-day and inter-
day precision of retention times (tR) and peak areas, linearity
testing for up to three concentration ranges, homoscedasticity
testing, and determination of limit of detection (LOD) and
limit of quantification (LOQ) for UV and mass spectrometric
detection, respectively. Results are given in Tables 2, 3, and 4.
Peak areas were corrected by IS for determination of precision
and linearity testing. All data were based on composite stan-
dard solutions containing BC and CPs dissolved in 50 % (v/v)
ACN–50 % (v/v) THF (including also the IS). Representative
chromatograms with UV and MS detection of BC and CPs
are given in Figs. 2 and 3.
Precision As part of the instrumental basis validation, intra-
and inter-day precision of tR and corrected peak areas were
determined for UV and MS detection. Therefore, a 2.0-μg/L
standard solution including the IS was injected repetitively.
For calculation of the intra-day precision, this standard solu-
tion was injected five times, whereas the inter-day precision
was based on three replicate injections on five consecutive
days. Coefficients of variation (CV) for tR are given only for
mass spectrometric data, since due to its higher spatial dis-
tance from the injection site, this detection system is expected
to give higher CVs of tR. Both intra- and inter-day precision of
tR were ≤1.5 % (corresponding to deviations of less than 2 s).
Precision of corrected peak areas was ≤4.1 % for intra-day and
≤5.1 % for inter-day measurements for UVand mass spectro-
metric detection, respectively.
Linearity Response linearity of DAD andOrbitrapMS for BC
and related CPs was tested with both detection systems hy-
phenated in series to UHPLC. Two ranges between 0.25 and
5.00 μg/mL were covered for UV. However, due to the higher
sensitivity of Orbitrap MS in comparison to UV detection,
another low concentration domain was included to extend
quantification to lower concentrations of CPs. Consistently,
three concentration ranges between 0.025 and 5.00 μg/mL
were tested with Orbitrap MS. Each calibration region
encompassed four to five different concentrations evenly
distributed over the respectively addressed domain. Re-
gression equations refer to the least square approach
and consider peak areas corrected by IS. In the case
non-linearity is revealed by MFT over the entire con-
centration range, a restriction to individual concentration
ranges based on the respective signal intensity will offer
improved quantification.
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DAD The tested concentration ranges for UV covered 0.25–
5.00 μg/mL. Analyte signals were acquired at their respective
wavelengths as given in Table 1. The highest concentration
tested, i.e., 5.00μg/mL, refers to the BC concentration intended
for subsequent application in primary cell cultures to reveal
possible genotoxic effects with concomitant oxidative stress.
The significance of intercepts was tested by means of an
ANOVA approach offered by SPSS. Additionally, ANOVA
Fig. 4 Detected masses and
isotope distribution for BC and
target apo-carotenals including a
comparison with theoretical
masses and theoretical isotope
distribution by means of the
provided software option







































Fig. 3 Extracted ion current
chromatograms of a standard
solution containing BC and target
CPs at 1.0μg/L. Identity of peaks:
A apo-12′-carotenal, B apo-10′-
carotenal, C apo-8′-carotenal, D
apo-4′-carotenal, E 5,6-epoxy-
BC, and F β-carotene
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was also applied to evaluate the linear regression model, i.e.,
the significance of the slope, which was confirmed in either
case (data not shown). Furthermore, linearity was tested by
means of MFT [61]. The coefficient of determination R2 which
Table 2 Validation parameters for calibration, linearity, and homoscedasticity testing for UHPLC–UV
Analytes Concentration range
(μg/mL)
Linear regression of instrument y=bx+a Linearity testing MFTb
Slope (= b) Intercept (= a) p (for a)a R2
Apo-12′ (n=24) 0.25–5.00 69,623.67 −488.18 >0.05 0.9995 Passed
Apo-10′ (n=24) 0.25–5.00 57,220.16 −1,229.99 >0.05 0.9993 Passed
Apo-8′ (n=24) 0.25–5.00 48,495.34 −991.18 >0.05 0.9996 Passed
Apo-4′ (n=15) 1.00–5.00 30,093.66 −2,689.44 <0.05* 0.9989 Passed
5,6-Epoxy-BC (n=15) 1.00–5.00 42,282.97 −2,090.50 >0.05 0.9992 Passed
BC (n=15) 1.00–5.00 28,645.50 −4,474.17 <0.05* 0.9966 Passed
Significance of slope, i.e., difference from 0, was proven at a confidence level of 0.95 by ANOVA for all regression equations
*p<0.05 refers to a significant difference of the intercept from 0
a Refers to the significance of coefficient a (= intercept) defined in the regression analysis
bMandel’s fitting test at a confidence level of 99.0 %






Slope (= b) Intercept (= a) p (for a)a R2
Apo-12′ n=36 0.025–5.00 2,885,781.45 484,003.92 <0.05* 0.9930 All passed
n=12 0.025–0.10 5,935,002.67 −60,738.67 0.9842
n=15 0.10–1.00 3,741,876.42 244,501.59 0.9886 4.97
n=15 1.00–5.00 2,646,606.57 1,333,099.77 0.9948
Apo-10′ n=36 0.025–5.00 3,051,117.73 520,893.39 <0.05* 0.9925 All passed
n=12 0.025–0.10 6,789,585.33 −110,993.17 0.9844
n=15 0.10–1.00 3,989,556.79 299,099.27 0.9870 3.28
n=15 1.00–5.00 2,823,405.40 1,319,197.93 0.9937
Apo-8′ n=36 0.025–5.00 2,504,361.99 1,125,333.03 <0.05* 0.9518 Passed
n=12 0.025–0.10 8,080,462.67 −65,880,50 0.9949 Passed
n=15 0.10–1.00 4,650,150.04 415,127.24 0.9890 Failed 2.29
n=15 1.00–5.00 1,837,987.17 3,513,752.77 0.9784 Passed
Apo-4′ n=36 0.025–5.00 2,000,767.56 1,219,207.53 <0.05* 0.9111 All passed
n=12 0.025–0.10 7,579.605.33 −105,700.17 0.9889
n=15 0.10–1.00 4,572,789.19 401,076.76 0.9815 2.67
n=15 1.00–5.00 1,274,599.87 3,811,724.60 0.9722
5,6-Epoxy-BC n=36 0.025–5.00 1,895,446.45 1,235,499.33 <0.05* 0.8817 All passed
n=12 0.025–0.10 7,489,329.33 −122,794.33 0.9848
n=15 0.10–1.00 4,547,332.80 344,518.48 0.9776 3.36
n=15 1.00–5.00 1,090,017.30 4,124,605.30 0.8653
BC n=36 0.025–5.00 2,383,560.31 1,172,578.04 <0.05* 0.8996 All passed
n=12 0.025–0.10 5,744,781.33 −110,962.83 <0.05* 0.9707
n=15 0.10–1.00 5,558,415.89 −40,412.59 >0.05 0.9825 3.95
n=15 1.00–5.00 1,394,933.97 4,744,144.23 <0.05* 0.8947
Significance of slope, i.e., difference from 0 was proven at a confidence level of 0.95 by ANOVA for all regression equations
*Refers to a significant difference (p<0.05) of the intercept from 0
a Refers to the significance of coefficient a (= intercept) defined in the regression analysis
bMandel’s fitting test at a confidence level of 99.0 %
cHomoscedasticity was tested within 0.1 and 5.0 μg/mL (n=10, respectively)
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indicates the correlation between the applied concentration and
the measured signal, i.e., peak area, but does not represent a
measure for linearity [62]—as frequently stated erroneously—
is given as well. All data are surveyed in Table 2. However, due
to the higher LOQ of apo-4′, 5,6-epoxy-BC, and BC that were
>0.50 μg/mL (see Table 4), linearity was only considered
between 1.00 and 5.00 μg/mL for these CPs (see Table 2).
The MFT indicated no improved fitting for a second order
regression model for either tested concentration domain. Even
when both tested concentration regions were combined in case
of apo-12′-, apo-10′-, and apo-8′, covering the entire domain
of 0.25–5.00 μg/mL, calculated F values derived by MFT
proved no significance (see Table 2). This implies linearity
over the entire concentration range tested in UV.
Orbitrap MS Due to the enhanced sensitivity of Orbitrap MS
in comparison to the previously addressed UV detection, the
tested concentration range was extended to lower concentra-
tions and divided into three consecutive domains, i.e., 0.025–
0.10, 0.10–1.00, and 1.00–5.00 μg/mL which allows for a
quantification of CPs and BC in considerably lower concen-
trations than with UV detection. Calculation of the signifi-
cance of the intercept, as well as linearity testing with MFT
and the evaluation of the linear regression model with
ANOVA, was performed as outlined in the previous para-
graph. Measured peak areas refer to extracted ions for the
monoisotopic masses of BC and target CPs acquired in SIM
mode (see Table 1) with a mass window of ±0.05m/z.
With increasing concentrations, results of Orbitrap MS
indicated a continuous reduction in the slope (Table 3). How-
ever, the statistical evaluation by MFT indicated significant
deviations from linearity only for apo-8′. In parallel, R2 are
also considerably reduced in comparison to corresponding
UV data, which additionally points to reduced correlations.
This is particularly true for the highest concentrations between
1.00 and 5.00 μg/mL, with the exception of apo-12′- and apo-
10′-carotenal (Table 3). Thus, current results indicate an in-
cipient saturation of detector response, and the selection of a
regression model for individual concentration regimes in cor-
respondence to experimentally measured peak areas seems
most advantageous. Although this might be arguable from
the statistical point of view, i.e., for MFT results which are
not significant, this strategy will reduce the uncertainty calcu-
lated as confidence interval when quantifying analytes via
regression.
Testing for homogeneity of variance
In addition, calibration data were tested for absence of
heteroscedasticity, since this would change the uncertainty of
analytical results in a concentration dependent manner. Due to
its higher sensitivity, quantification of CPs will be done by
Orbitrap MS with optional confirmation of concentrations by
UV in case analytes are situated in appropriate concentration
domains. Therefore, homogeneity of variance was tested for
ESI–LTQ–Orbitrap MS by analyzing standard solutions of
CPs (including IS) at concentration levels of 0.1 and 5.0μg/mL
by ten injection replicates, respectively. Fcalc was derived by
dividing the relative variance of the higher by the relative
variance of the lower concentration. In all tested cases, Fcalc
was lower than the tabulated Ftab (=5.34), confirming homo-
geneity of relative variances over the tested range at a 99 %
confidence level (Table 3) [61].
Instrumental limit of detection and limit of quantification
LOD and LOQ of BC and CPs were calculated for UV and
OrbitrapMS detection according to the ICH guideline Q2(R1)
applying the so-called standard deviation approach. Thereby,
the standard deviation of signals has to be calculated either
from the noise of a blank or from a standard solution or sample
containing the respective analytes at low concentrations [59].
Instrumental LOD and LOQ were determined from a com-
bined standard solution containing BC and CPs at
0.025 μg/mL. LOD and LOQ both for the UV and the MS
measurement step were calculated to address possible differ-
ences and derive applicable minimum concentrations for lin-
earity testing. Baseline fluctuation, i.e. noise, was calculated
differently for UV and MS detection. For UV, noise was
calculated from the lowest standard concentration considered
in linearity testing, i.e., 0.10 μg/mL. Thereby, a retention
window considering twice the base peak width on either side
of the respective analyte peaks was constructed for determi-
nation of the baseline noise. In case of MS detection, noise
values given by the software via the signal-to-noise option in
the SIM mode were derived for either analyte signal. LOD
was calculated as the 3.3-fold of the determined noise divided
by the slope of the peak height calibration curve over the low
concentration domain for either CP. For LOQ, the 10-fold
noise is considered otherwise duplicating the calculation ap-
proach for LOD [59]. Since both LOD and LOQ refer to
Table 4 Limit of detection and
limit of quantification for BC and
CPs
Apo-12′ Apo-10′ Apo-8′ Apo-4′ 5,6-Epoxy-BC BC
LOD (ng/mL) UV 24.6 17.3 30.0 293.5 221.2 231.4
MS 0.0109 0.034 0.0064 0.0128 0.0151 0.0094
LOQ (ng/mL) UV 74.6 52.6 87.1 889.4 639.9 741.3
MS 0.0329 0.1024 0.0193 0.0387 0.0458 0.0285
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signal heights, calibration curves for peak heights had to be
calculated. Due to previous linearity data, considered concen-
tration ranges were selected close to preliminarily estimated
LOQs to prevent deviation from linearity. Selected concentra-
tion ranges for linearity testing of peak heights comprised 1.00
to 5.00 μg/mL for UV and 0.10 to 1.00 μg/mL for Orbitrap
MS. For either concentration range linearity was proven by
MFT as outlined in the previous section (data not shown).
Calculated LODs and LOQs for UV detection and MS are
provided in Table 4. Depending on the respective UV absor-
bance, LOQs for UV detection were between 52.6 and
889.4 ng/mL. Remarkably, LOQs for Orbitrap MS were be-
tween 19.3 and 102.4 ng/L and thus between 5.15×102- and
2.60×104-fold smaller than their UV counterparts (see Ta-
ble 4). The low LOD and LOQ realized for BC with Orbitrap
MS are related to electrochemical oxidation and formation of
radical ions (M•+) as described previously [56, 57].
Validation of SPE
Intra-day and inter-day precision of SPE recovery
The SPE protocol pursued for non-volatile CPs and BC refers
to [47]. Briefly, the principle of interaction between the phenyl
stationary phase employed in SPE and the analytes is mainly
based on π–π interactions. In the current case, the entire 2-mL
SPE eluate was applied to UHPLC subsequent to the afore-
mentioned solvent change, but operation with a 1-mL aliquot
is applicable as well when employing GC–EI–MS and
UHPLC–DAD–ESI–Orbitrap MS in parallel. The intra-day
precision of SPE was determined at two concentration levels
within the single-laboratory validation, based on five SPE
replicates within 1 day, respectively. Model samples for SPE
were prepared by spiking MEM with a combined stock solu-
tion of CPs and BC to give final concentrations of 1.0 and
0.5 μg/mL for either analyte. Recoveries were between 65.8
and 102.4 % with corresponding CVs ≤4.0 %, respectively
(Table 5; n=5). A comparison of the recovery between 1.0 and
0.5 μg/mL (intra-day) by means of a two-sided independent
sample t test revealed no significant differences. Moving to
target cells other than hepatocytes might require the inclusion
of fetal calf serum in the cell culture medium. Therefore, SPE
recoveries and related intra-day precision have additionally
been tested for MEM including 10% (v/v) fetal calf serum and
addition of BC and CPs to provide final concentrations of
1.0 μg/mL, respectively. Recoveries for BC and CPs were
between 64.3 and 99.8 % with CV <5.0 % (n=3). Indeed,
recoveries and intermediate precision perfectly corresponded
with data derived from fetal calf serum deficient MEM sam-
ples for BC and all CPs.
Inter-day precision was based on three extractions per day
performed over five consecutive days. Spiked model samples
were prepared independently on either day. Inter-day recov-
eries were between 66.6 and 91.1% (CV ≤6.2%; n=15). One-
factor ANOVA of inter-day recoveries revealed significant
differences for apo-10′-, apo-4′, 5,6-epoxy-BC, and BC be-
tween individual days, whereas Levene’s test for testing ho-
mogeneity of variance was only significant for 5,6-epoxy-BC
and BC. The stationary phenyl phase previously applied in the
SPE of volatile CPs [47] appears thus equally applicable for
the extraction of highly hydrophobic BC and non-volatile
target CPs.
Specificity
To confirm the method specificity, fresh MEM and MEM
after 3 h incubation in primary hepatocyte cultures were
subjected to SPE and subsequently analyzed by UHPLC–
DAD–ESI–Orbitrap MS. No interfering peaks were ob-
served in UV and MS chromatograms in either case (data
not shown). However, with the inclusion of fetal calf
serum, a slight blank was revealed that was ≤3 % when
compared to peak area of the BC concentration applied in
culture treatment (data not shown). This has to be consid-
ered when analyzing low BC concentrations in the pres-
ence of fetal calf serum.
SPE linearity for spiked MEM samples
Preliminary results of BC degradation in cell cultures revealed
BC, 5,6-epoxy-BC, and apo-4′ in quantifiable amounts (data
not shown). Therefore, SPE linearity was confirmed by
Table 5 Intra-day and inter-day
SPE recovery for BC and non-
volatile CPs
a The sample size (n=15) refers to
three SPEs performed on five
consecutive days
Concentration Recovery (%)
Apo-12′ Apo-10′ Apo-8′ Apo-4′ 5,6-Epoxy-BC BC
1.0 μg/mL Intra-day (n=5) 74.4 94.6 84.5 84.1 65.8 101.6
CV% 1.4 1.4 3.1 4.0 2.7 3.6
Inter-day (n=15)a 73.4 93.2 89.5 84.8 66.6 91.1
CV% 3.4 6.2 5.0 3.8 5.8 4.6
0.5 μg/mL Intra-day (n=5) 73.2 90.8 84.8 87.2 66.0 102.4
CV% 3.6 3.7 3.3 2.6 2.0 3.2
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spiking MEM with these analytes in appropriate concentra-
tions. Apo-4′ and 5,6-epoxy-BC were quantified by Orbitrap
MS. The 100- to 4,000-fold higher concentrations of BC in
comparison to these CPs were due to its application in form of
the treatment solution and required quantification by DAD.
Five concentrations distributed equidistantly over the tested
range were analyzed for either compound. In addition, aMEM
blank was analyzed. Subsequent to SPE, each concentration
was injected in triplicate. Derived calibration curves refer to
the mean of the injection replicates, respectively. All calibra-
tion curves were linear as proven by MFT. Intercept was not
significant for apo-4′and 5,6-epoxy-BC (see Table 6). The
addition of 10 % FCS to cell culture media showed neither
changes in tR of analytes nor in their recovery and recovery
precision of SPE. Moreover, the influence on the selectivity
was minute, obviously requiring consideration only at greatly
reduced concentrations of BC. However, this does not neces-
sarily guarantee the maintenance of regression slopes in UV
andMS detection and SPE calibration nor the respective linear
ranges confirmed for serum deficient culture media (see
Tables 2, 3, and 6). Actually, matrix effects due to addition
of fetal calf serum might alter these parameters and addition-
ally change LOD and LOQ. In case of quantification in the
presence of fetal calf serum, a comprehensive further valida-
tion that is beyond the current scope is mandatory to assure
correct concentrations.
Identification of CPs in treated cell cultures
The validated SPE UHPLC–DAD–ESI–Orbitrap MS method
was applied to cell cultures of primary rat hepatocytes. Sub-
sequent to the addition of the BC treatment solution to primary
cultures to give a final BC concentration of 10 μM
(5360 ng/mL), primary rat hepatocyte cultures were incubated
for 3 h and simultaneously subjected to oxidative stress in-
duced by different means. This approach targets to elucidate
possible differences in the generated profiles and concentra-
tions of CPs that were produced either directly in the medium
and/or in the cells with subsequent secretion. Oxidative stress
was either induced by (i) 40μmol/LDMNQ [21], (ii) 10μmol/L
hydrogen peroxide (H2O2) [63, 64], or (iii) 10 μmol/L H2O2
in the presence of 10 μmol/L Fe(II)lactate (the latter simulat-
ing the Fenton reaction) [50]. The H2O2 treatment concentra-
tionwas selected 10-fold lower than published elsewhere [65],
to assure integrity of hepatocytes. The H2O2 and Fe(II)lactate
concentrations were selected equimolar and exerted no cyto-
toxic effects over the incubation interval [66].
Application of DMNQ was designed as initial treat-
ment since DMNQ induces oxidative stress after its
uptake into the cell. This is considered to simulate the
cell physiological environment of patients subjected to
strong oxidative stress, such as smokers. CPs derived
from this treatment and proven not to result from au-
toxidation in the culture medium can thus be assigned
to enzymatic (and possibly non-enzymatic) formation
taking place in the cell with subsequent secretion into
the medium. The second approach applied H2O2 as an
oxidant agent to promote oxidative stress. In the last
approach, hepatocytes were simultaneously incubated
with H2O2 and Fe(II)lactate. According to the Fenton
reaction, H2O2 reacts with Fe
2+ with consecutive gener-
ation of OH− and •OH and Fe3+ [50]. In addition, either
treatment procedure was also performed (i) by addition
of BC in the absence of cells and (ii) in the presence of
cells, but without addition of BC. As a further control,
(iii) hepatocytes were treated with BC without induction
of oxidative stress. All other experimental frame condi-
tions were maintained. To prevent instrumental sample
carry-over between analytical runs and thus false posi-
tive results, measurement series comprising samples of
individual treatments were always completed with blank
injections, which provided no signals.
In case cells were treated with BC and subjected to
oxidative stress, 5,6-epoxy-BC and apo-4′ were detected
in addition to BC, irrespective of the mode of oxidative
stress (see Table 7). Remarkably, cell cultures treated with
BC but without oxidative stress showed the same profile of
CPs, i.e., 5,6-epoxy-BC and apo-4′. However, apo-4′ was
only detected in quantifiable amounts in hepatocyte cultures
of one rat, but not in cultures of the other in either case. If
only BC was added to cell culture medium without cells,
5,6-epoxy-BC was detected as well but not apo-4′,





Slope (= b) ANOVA Intercept (= a) p (for a)a R2
Apo-4′ 0–0.0125a 1,107,257.1 p<0.05* 425.8 >0.05 0.995 Passed
5,6-Epoxy-BC 0–0.50a 1,019,107.4 p<0.05* 8450.5 >0.05 0.991 Passed
BC 10–50 6,429,177.1 p<0.05* 191,897.8 <0.05* 0.992 Passed
a In either case, a blank MEM was passed over SPE
bMandel’s fitting test at a confidence level of 99.0 %
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irrespective of the mode of oxidative stress and even in its
absence (Table 7). Based on these results, 5,6-epoxy-BC
which constitutes the major CP under the selected experimen-
tal conditions seems to be formed irrespective of externally
induced oxidative stress and the presence of cells. Since no
CPs were detected after SPE of MEM solutions spiked with
BC, the extraction step can be excluded as a causative source
for BC degradation. Instead, the ambient oxygen pressure
prevailing during the 3-h incubation period appears sufficient
to induce oxidation of BC, forming 5,6-epoxy BC but none of
the other target CPs. This provides essential information for
the interpretation of adverse effects on cells, since even by
exclusive application of BC encountered effects might be
related to the formed epoxy variant of BC. In case of apo-4′,
the situation is more intriguing. Since this CP was never found
in the absence of cells, formation is most likely mediated by
cells but depends apparently on their individual response, as
not all test animals provided this CP. Altogether, the applica-
tion of the validated SPE UHPLC–DAD–ESI–Orbitrap MS
method allowed for a deeper insight into CP profiles and
quantification of individual target CPs formed in the course
of in vitro experiments. This is an essential prerequisite for the
interpretation of adverse cell effects when trying to reveal
possible mechanisms attempting to mimic the BC paradox
in probationers suffering from oxidative stress, such as
smokers and asbestos workers.
Conclusion
For the first time this work presents a fast UHPLC method
employing sub-2 μm core–shell particles for separation of BC
and related long-chain CPs. UHPLC hyphenation to DAD
and—via electrospray ionization—to LTQ–Orbitrap MS
allows the identification and quantification of these analytes
in cell culture media. Preceding offline SPE as well as the
applied internal standard are shared with a GC–EI–MS meth-
od for volatile CPs previously published by our group [47].
This permits a simultaneous SPE of volatile and non-volatile
CPs and BC under identical extraction conditions and thus a
more comprehensive investigation of BC degradation in
in vitro systems subjected to oxidative stress. The method
was validated for BC and selected CPs which are currently
considered most relevant for adverse effects observed in risk
groups of BC intervention studies. Therefore, intra-day and
inter-day precision for peak areas and retention times, linearity
of detector responses, LOD and LOQ, as well as intra- and
inter-day SPE recoveries were determined. LOQs between
19.3 and 102.4 ng/L for Orbitrap MS allowed for a trace
detection of CPs. The profiling and identification of CPs by
LTQ–Orbitrap MS with high mass accuracy as well as their
quantification in primary cell cultures is essential to relate
observed genotoxic effects with prevailing ensembles of
CPs. When culture media were incubated with BC, 5,6-
Table 7 Non-volatile CPs of BC identified in MEMwithout and with cells after addition of 10 μmol/L BC under control conditions and oxidative stress
induced by different chemical means (DMNQ, H2O2, and Fe/H2O2), respectively
Apo-4′a (μg/mL) 5,6-Epoxy-BC (μg/mL) BC (μg/mL)
Treatment in MEM without cells
BC control Mean n.d. 0.33 4.79
s 0.21 0.24
BC DMNQ Mean n.d. 0.17 4.99
s 0.03 0.10
BC H2O2 Mean n.d. 0.17 5.14
s 0.02 0.17
BC Fe/H2O2 Mean n.d. 0.16 4.90
s 0.04 0.29
Treatment in MEM with primary hepatocytes
Control BC Mean 0.005 0.15 4.65
s 0.007 0.04 0.57
BC DMNQ Mean 0.008 0.11 4.67
s 0.009 0.03 0.33
BC H2O2 Mean 0.006 0.10 4.64
s 0.008 0.02 0.58
BC Fe/H2O2 Mean 0.006 0.12 4.52
s 0.007 0.03 0.16
n.d. not determined
aApo-4′ was only detected in primary cultures derived from one rat (for details, see text)
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epoxy-BC was quantified after 3 h irrespective of oxidative
stress. Apparently the formation occurs during the incubation
by ambient oxygen. The observed concentration of this CP
was equivalent in the presence and absence of primary rat
hepatocytes. However, within a primary hepatocyte popula-
tion derived from one rat, an early long-chain CP, i.e., apo-4′-
carotenal, was generated under oxidative stress in all tested
cultures, but not in a second biological replicate. This might
indicate individual degradation kinetics over the investigated
3-h incubation. Since the method has proven its applicability
for cell culture media, it will provide an essential input for an
improved interpretation of in vitro models and contribute to a
future deciphering of the BC paradox by testing various BC
concentrations with increased biological replicates.
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